BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

B3GALT5


Suggest Content
Advertise Here
Gene DB Home
Symbol:B3GALT5
Name(s):UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5
Type:protein-coding
Organism:Homo sapiens
Synonyms:B3GalT-V, B3GalTx, B3T5, GLCT5, beta3Gal-T5
Links: Pubmed, Entrez Gene, GeneCards, Map Viewer.

Gene Information from Publications

Publication Link Summary of findings
16112824 case study of the endogenous retrovirus long terminal repeat promoter of this enzyme
15263012 2.3-kb 5'-flanking region of the human beta-1,4-GalT V gene was cloned and the region -116/-18 relative to the transcription start site as that having promoter activity.

Recent Publications on B3GALT5:

Pubmed Logo
Fold-recognition and comparative modeling of human beta3GalT I, II, IV, V and VI and beta3GalNAcT I: prediction of residues conferring acceptor substrate specificity.
beta3GalTs are type II transmembrane proteins that transfer galactose from...
12th October, 2007
School of Biosciences and Bioengineering, Indian Institute of Technology J Mol Graph Model. 2007 Jul;26(1):255-68. Epub 2006 Dec 15.
DOI Direct Link
Comprehensive enzymatic characterization of glycosyltransferases with a beta3GT or beta4GT motif.
Bioinformatics is a very powerful tool in the field of glycoproteomics, as...
18th May, 2007
Glycogene Function Team of Research Center for Glycoscience, National Methods Enzymol. 2006;416:91-102.
DOI Direct Link
Comparative analysis of retroviral and native promoters driving expression of beta1,3-galactosyltransferase beta3Gal-T5 in human and mouse tissues.
Beta1,3-galactosyltransferase beta3Gal-T5 is highly expressed in the...
9th February, 2007
Department of Biomedical Sciences Experimental and Clinical, University of J Biol Chem. 2007 Jan 5;282(1):49-57. Epub 2006 Nov 15.
DOI Direct Link
Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity.
Sialyl Lewis A (SLe(a)), Lewis A (Le(a)), and Lewis B (Le(b)) have been...
23rd August, 2006
Division of Clinical Immunology, Karolinska Institutet, Karolinska Glycobiology. 2006 Jul;16(7):584-93. Epub 2006 Feb 16.
DOI Direct Link
Endogenous retrovirus long terminal repeats as ready-to-use mobile promoters: the case of primate beta3GAL-T5.
Throughout the course of vertebrate evolution, germline retroviral...
4th May, 2006
Terry Fox Laboratory, BC Cancer Agency, Vancouver, British Columbia, Gene. 2005 Dec 30;364:2-12. Epub 2005 Aug 22.
DOI Direct Link

View more research publications.

B3GALT5 results (if any) from reagent suppliers

Google CSE Logo

Search Bioportfolio and other Life Science Sites for B3GALT5
This page has been viewed 44 times
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional